Pharmacological basis for the therapeutic applications of slow-channel blocking drugs (Q40338219)

19 September 2017

1 reference

title

Pharmacological basis for the therapeutic applications of slow-channel blocking drugs (English)

1 reference

19 September 2017

B N Singh

1

1 reference

19 September 2017

1 August 1982

1 reference

19 September 2017

1 reference

19 September 2017

33

1 reference

19 September 2017

8

1 reference

19 September 2017

492-515

1 reference

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

19 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Membrane calcium current in ventricular myocardial fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Cardiac muscle: excitability and passive electrical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

New perspectives in the pharmacologic therapy of cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effects of atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effect of verapamil on normal sinoatrial node function and on sick sinus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effect of nifedipine on atrioventricular conduction as compared with verapamil. Intracardiac electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Comparative clinical electrophysiologic effects of diltiazem, verapamil and nifedipine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effect of Digitalis on Atrioventricular Conduction and Circus-Movement Tachycardias in Patients with Wolff-Parkinson-White Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effect of septal myotomy and myectomy on left ventricular systolic function at rest and during exercise in patients with IHSS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effects of intravenous verapamil on hemodynamics in patients with heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Effects of verapamil on myocardial performance in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331978203300802

10.1177/000331978203300802

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference

PubMed ID

7051905